Daniele Noel
Overview
Explore the profile of Daniele Noel including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
148
Citations
6416
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
21.
Hospitalizations for infections in primary Sjögren's syndrome patients: a nationwide incidence study
Goulabchand R, Makinson A, Morel J, Witkowski-Durand-Viel P, Nagot N, Loubet P, et al.
Ann Med
. 2022 Sep;
54(1):2672-2680.
PMID: 36173925
Background: Primary Sjögren's syndrome (pSS) is an autoimmune disease with increased risk of infections. Here, we assessed whether pSS patients were at higher risk of hospitalization for community and opportunistic...
22.
Bertolino G, Maumus M, Jorgensen C, Noel D
Biomedicines
. 2022 Sep;
10(9).
PMID: 36140386
Extracellular vesicles (EVs) are being widely investigated as acellular therapeutics in regenerative medicine applications. EVs isolated from mesenchymal stromal cells (MSCs) are by far the most frequently used in preclinical...
23.
Salvador J, Berthelot J, Bony C, Robin B, Lai Kee Him J, Noel D, et al.
Acta Biomater
. 2022 Sep;
153:97-107.
PMID: 36113724
Tissue engineering aims to restore or replace different types of biological tissues through the association of cells, biologic factors and biomaterials. Currently, stem cells arise as a major cell source...
24.
Goulabchand R, Gabelle A, Ayrignac X, Malafaye N, Labauge P, Noel D, et al.
J Clin Med
. 2022 Apr;
11(7).
PMID: 35407586
Primary Sjögren’s syndrome (pSS) can be associated with neurological and cognitive involvement, negatively affecting patients’ quality of life. The aim of this study was to assess whether pSS patients are...
25.
Donate P, Lamarre Y, Pino-Lagos K, Noel D, Almeida F
Front Immunol
. 2022 Mar;
13:867324.
PMID: 35309347
No abstract available.
26.
Faydherbe De Maudave A, Leconet W, Toupet K, Constantinides M, Bossis G, de Toledo M, et al.
J Control Release
. 2021 Dec;
341:578-590.
PMID: 34915070
Monoclonal antibodies (mAbs) are large size molecules that have demonstrated high therapeutic potential for the treatment of cancer or autoimmune diseases. Despite some excellent results, their intravenous administration results in...
27.
Goulabchand R, Malafaye N, Jacot W, Viel P, Morel J, Lukas C, et al.
Autoimmun Rev
. 2021 Oct;
20(12):102987.
PMID: 34718160
The relationship between cancer and primary Sjögren's syndrome (pSS) is uncertain. While the increased risk of hematological malignancies is well-known, data on the comparative incidence of solid neoplasms is conflicting....
28.
Rozier P, Maumus M, Maria A, Toupet K, Jorgensen C, Guilpain P, et al.
Cells
. 2021 Oct;
10(10).
PMID: 34685707
Background: Systemic sclerosis (SSc) is a severe autoimmune disease for which mesenchymal stromal cells (MSCs)-based therapy was reported to reduce SSc-related symptoms in pre-clinical studies. Recently, extracellular vesicles released by...
29.
Silva A, Morille M, Piffoux M, Arumugam S, Mauduit P, Larghero J, et al.
Adv Drug Deliv Rev
. 2021 Oct;
179:114001.
PMID: 34673131
Extracellular vesicles (EV) are emergent therapeutic effectors that have reached clinical trial investigation. To translate EV-based therapeutic to clinic, the challenge is to demonstrate quality, safety, and efficacy, as required...
30.
Maumus M, Fonteneau G, Ruiz M, Assou S, Boukhaddaoui H, Pastoureau P, et al.
Cell Biosci
. 2021 Oct;
11(1):183.
PMID: 34663442
Background: Articular cartilage is a complex tissue with poor healing capacities. Current approaches for cartilage repair based on mesenchymal stromal cells (MSCs) are often disappointing because of the lack of...